These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 30197049)
1. Association of Whole-Genome and NETRIN1 Signaling Pathway-Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank. Barbu MC; Zeng Y; Shen X; Cox SR; Clarke TK; Gibson J; Adams MJ; Johnstone M; Haley CS; Lawrie SM; Deary IJ; ; ; McIntosh AM; Whalley HC Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):91-100. PubMed ID: 30197049 [TBL] [Abstract][Full Text] [Related]
2. Genetic Study of White Matter Integrity in UK Biobank (N=8448) and the Overlap With Stroke, Depression, and Dementia. Rutten-Jacobs LCA; Tozer DJ; Duering M; Malik R; Dichgans M; Markus HS; Traylor M Stroke; 2018 Jun; 49(6):1340-1347. PubMed ID: 29752348 [TBL] [Abstract][Full Text] [Related]
3. A Combined Pathway and Regional Heritability Analysis Indicates NETRIN1 Pathway Is Associated With Major Depressive Disorder. Zeng Y; Navarro P; Fernandez-Pujals AM; Hall LS; Clarke TK; Thomson PA; Smith BH; Hocking LJ; Padmanabhan S; Hayward C; MacIntyre DJ; Wray NR; ; Deary IJ; Porteous DJ; Haley CS; McIntosh AM Biol Psychiatry; 2017 Feb; 81(4):336-346. PubMed ID: 27422368 [TBL] [Abstract][Full Text] [Related]
4. Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank. Reus LM; Shen X; Gibson J; Wigmore E; Ligthart L; Adams MJ; Davies G; Cox SR; Hagenaars SP; Bastin ME; Deary IJ; Whalley HC; McIntosh AM Sci Rep; 2017 Feb; 7():42140. PubMed ID: 28186152 [TBL] [Abstract][Full Text] [Related]
5. Subcortical volume and white matter integrity abnormalities in major depressive disorder: findings from UK Biobank imaging data. Shen X; Reus LM; Cox SR; Adams MJ; Liewald DC; Bastin ME; Smith DJ; Deary IJ; Whalley HC; McIntosh AM Sci Rep; 2017 Jul; 7(1):5547. PubMed ID: 28717197 [TBL] [Abstract][Full Text] [Related]
6. White Matter Tract Integrity Is Reduced in Depression and in Individuals With Genetic Liability to Depression. Nothdurfter D; Jawinski P; Markett S Biol Psychiatry; 2024 Jun; 95(12):1063-1071. PubMed ID: 38103877 [TBL] [Abstract][Full Text] [Related]
7. White Matter Microstructure and Its Relation to Longitudinal Measures of Depressive Symptoms in Mid- and Late Life. Shen X; Adams MJ; Ritakari TE; Cox SR; McIntosh AM; Whalley HC Biol Psychiatry; 2019 Nov; 86(10):759-768. PubMed ID: 31443934 [TBL] [Abstract][Full Text] [Related]
8. Vesicular monoamine transporter 1 gene polymorphism and white matter integrity in major depressive disorder. Won E; Han KM; Kang J; Kim A; Yoon HK; Chang HS; Park JY; Lee MS; Greenberg T; Tae WS; Ham BJ Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():138-145. PubMed ID: 28408293 [TBL] [Abstract][Full Text] [Related]
9. Polygenic risk and white matter integrity in individuals at high risk of mood disorder. Whalley HC; Sprooten E; Hackett S; Hall L; Blackwood DH; Glahn DC; Bastin M; Hall J; Lawrie SM; Sussmann JE; McIntosh AM Biol Psychiatry; 2013 Aug; 74(4):280-6. PubMed ID: 23453289 [TBL] [Abstract][Full Text] [Related]
10. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures. Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844 [TBL] [Abstract][Full Text] [Related]
11. Polygenic Scores for Neuropsychiatric Traits and White Matter Microstructure in the Pediatric Population. Jansen PR; Muetzel RL; Polderman TJC; Jaddoe VW; Verhulst FC; van der Lugt A; Tiemeier H; Posthuma D; White T Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Mar; 4(3):243-250. PubMed ID: 30243642 [TBL] [Abstract][Full Text] [Related]
13. White matter abnormalities in adolescents with major depressive disorder. Bessette KL; Nave AM; Caprihan A; Stevens MC Brain Imaging Behav; 2014 Dec; 8(4):531-41. PubMed ID: 24242685 [TBL] [Abstract][Full Text] [Related]
14. Vascular risk factors, white matter microstructure, and depressive symptoms: a longitudinal analysis in the UK Biobank. Blöchl M; Schaare HL; Kumral D; Gaebler M; Nestler S; Villringer A Psychol Med; 2024 Jan; 54(1):125-135. PubMed ID: 37016768 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide by environment interaction studies of depressive symptoms and psychosocial stress in UK Biobank and Generation Scotland. Arnau-Soler A; Macdonald-Dunlop E; Adams MJ; Clarke TK; MacIntyre DJ; Milburn K; Navrady L; ; ; Hayward C; McIntosh AM; Thomson PA Transl Psychiatry; 2019 Feb; 9(1):14. PubMed ID: 30718454 [TBL] [Abstract][Full Text] [Related]
16. Expression quantitative trait loci-derived scores and white matter microstructure in UK Biobank: a novel approach to integrating genetics and neuroimaging. Barbu MC; Spiliopoulou A; Colombo M; McKeigue P; Clarke TK; Howard DM; Adams MJ; Shen X; Lawrie SM; McIntosh AM; Whalley HC Transl Psychiatry; 2020 Feb; 10(1):55. PubMed ID: 32066731 [TBL] [Abstract][Full Text] [Related]
17. A COMPREHENSIVE EXAMINATION OF WHITE MATTER TRACTS AND CONNECTOMETRY IN MAJOR DEPRESSIVE DISORDER. Olvet DM; Delaparte L; Yeh FC; DeLorenzo C; McGrath PJ; Weissman MM; Adams P; Fava M; Deckersbach T; McInnis MG; Carmody TJ; Cooper CM; Kurian BT; Lu H; Toups MS; Trivedi MH; Parsey RV Depress Anxiety; 2016 Jan; 33(1):56-65. PubMed ID: 26477532 [TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment with and without depression history: an analysis of white matter microstructure. Duffy SL; Paradise M; Hickie IB; Lewis SJ; Naismith SL; Lagopoulos J J Psychiatry Neurosci; 2014 Mar; 39(2):135-43. PubMed ID: 24359878 [TBL] [Abstract][Full Text] [Related]
19. Nicotine Effects on White Matter Microstructure in Young Adults. Kangiser MM; Thomas AM; Kaiver CM; Lisdahl KM Arch Clin Neuropsychol; 2019 Jan; 35(1):10-21. PubMed ID: 31009035 [TBL] [Abstract][Full Text] [Related]
20. White matter microstructure is associated with hyperactive/inattentive symptomatology and polygenic risk for attention-deficit/hyperactivity disorder in a population-based sample of adolescents. Albaugh MD; Hudziak JJ; Ing A; Chaarani B; Barker E; Jia T; Lemaitre H; Watts R; Orr C; Spechler PA; Lepage C; Fonov V; Collins L; Rioux P; Evans AC; Banaschewski T; Bokde ALW; Bromberg U; Büchel C; Quinlan EB; Desrivières S; Flor H; Frouin V; Gowland P; Heinz A; Ittermann B; Martinot JL; Nees F; Orfanos DP; Paus T; Poustka L; Fröhner JH; Smolka MN; Walter H; Whelan R; Schumann G; Garavan H; Potter A Neuropsychopharmacology; 2019 Aug; 44(9):1597-1603. PubMed ID: 30952157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]